Formulife, LLC
Allen, TX, United States
Due-diligence reportFind an accredited testing lab and confirm its scope covers your product and methods.
Formulife, LLC is a dietary supplement manufacturer in Allen, TX, United States, certified to NSF/ANSI 455-2 GMP, with 1 manufacturing facility on NSF’s public NSF/ANSI 455 listing as of November 19, 2026. It also has an Informed Manufacturer certified facility (not a GMP audit). It is also a USDA Organic certified operation. Listed dosage forms: capsules, powders, softgels and tablets.
- Website
- formulifesupplements.com
- Phone
- 214-221-4911
- Facilities listed
- 3
- Last checked
Dosage forms
As listed for this company’s facilities by NSF (certificate scope) and Informed Manufacturer (certified facility capabilities).
Certified facilities
Manufacturing (2)
1253 Andrews Parkway, Allen, TX 75002, United States
Listed by NSF (NSF/ANSI 455)
- Dry Formulation
- Encapsulation
- Mixing
- Packaging/Labeling Operation
- Packaging/Labeling Operation - Primary Packaging
- Packaging/Labeling Operation - Secondary Packaging
- Warehousing
United States
Listed by Informed Manufacturer (not a GMP audit)
Distribution (1)
4500 South Hardin Boulevard, Suite 430, McKinney, TX 75070, United States
Listed by NSF (NSF/ANSI 455)
- Warehousing
How Formulife, LLC compares
Among the 769 manufacturers we list, as of our last check.
- One of 15 capsule manufacturers we list in Texas, and 325 in the United States. All capsule manufacturers in the USA · All in Texas
- One of 9 tablet manufacturers we list in Texas, and 228 in the United States. All tablet manufacturers in the USA · All in Texas
- One of 10 softgel manufacturers we list in Texas, and 160 in the United States. All softgel manufacturers in the USA · All in Texas
- On 3 of the registries we check: NSF/ANSI 455-2, Informed Manufacturer (not a GMP audit) and USDA Organic. 9 of the 769 manufacturers we list are on 3 or more.
- Has 2 listed manufacturing or packaging facilities; 71% of the manufacturers we list have fewer.
FDA recall records
No food or dietary supplement recall found under the name Formulife, LLC in FDA’s enforcement reports, as of .
We match FDA records by company name only. A recall listed under a different name won’t appear here, and a different company with the same name could. FDA’s food enforcement records start in June 2012. How we check
FDA inspections
FDA lists 9 food or dietary supplement inspections at facilities matching Formulife, LLC, from 2011 to 2025, as of . 1 found no objectionable conditions, 4 found conditions the firm was left to correct, and 4 led FDA to recommend official action.
No action indicated · No objectionable conditions found
Inspected
Mckinney, Texas
FEI 3025065421
Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm
Inspected
Allen, Texas
10 citations posted:
- Registration (21 CFR 108.25(c)(1))
- Process filing (21 CFR 108.25(c)(2))
- Approved school (21 CFR 108.25(f))
- Specifications - components (21 CFR 111.70(b))
See all 10 citations
Registration (21 CFR 108.25(c)(1))
You did not register and file Form FDA 2541 (food canning establishment registration) with FDA within 10 days after first engaging in the manufacture, processing and packaging of acidified foods.
Process filing (21 CFR 108.25(c)(2))
You did not provide FDA with information on the scheduled process for a new acidified food before packing the food.
Approved school (21 CFR 108.25(f))
Personnel involved in acidification, pH control, heat treatment and critical factors of the operation were not under the operating supervision of a person who attended and satisfactorily completed a school approved by the FDA Commissioner.
Specifications - components (21 CFR 111.70(b))
For component(s) used in the manufacture of a dietary supplement, you did not establish identity specifications and necessary specifications to ensure the specifications for purity, strength, and composition of the dietary supplement are met.
Specifications - labels, packaging (21 CFR 111.70(d))
You did not establish label and packaging specifications.
Specifications - finished dietary supplement (21 CFR 111.70(e))
You did not establish product specifications for identity, purity, strength, composition and limits on contamination.
Quality control - processes, specifications, written procedures (21 CFR 111.105(a))
Your quality control personnel did not approve or reject specifications and written procedures that may affect the identity, purity, strength, or composition of a dietary supplement.
Master manufacturing record - record requirements (21 CFR 111.210)
Your master manufacturing record did not include all required information.
Batch record - required information (21 CFR 111.260)
Your batch production record did not include all required information.
Quality control procedures (21 CFR 114.80(a))
Appropriate quality control procedures are not employed to ensure that finished foods do not present a health hazard.
FEI 3007844828
Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm
Inspected
Allen, Texas
1 citation posted:
- Allergen preventive controls - Implement (21 CFR 117.135(a)(1))
Full citation text
Allergen preventive controls - Implement (21 CFR 117.135(a)(1))
You did not implement your allergen preventive control procedures.
FEI 3007844828
Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm
Inspected
Allen, Texas
1 citation posted:
- Appropriate tests, examinations; certificate of analysis (21 CFR 111.75(a)(2))
Full citation text
Appropriate tests, examinations; certificate of analysis (21 CFR 111.75(a)(2))
You did not conduct appropriate tests or examinations or rely on a certificate of analysis to determine whether components met established specifications.
FEI 3007844828
Official action indicated · Regulatory or administrative action recommended
Inspected
Allen, Texas
8 citations posted:
- Specifications - component identity (21 CFR 111.70(b)(1))
- Specifications-component purity, strength, composition (21 CFR 111.70(b)(2))
- Specifications - identity, purity, strength, composition (21 CFR 111.70(e))
- Specifications met - component identity (21 CFR 111.73)
See all 8 citations
Specifications - component identity (21 CFR 111.70(b)(1))
You did not establish an identity specification for each component.
Specifications-component purity, strength, composition (21 CFR 111.70(b)(2))
You did not establish component specifications for purity, strength and composition.
Specifications - identity, purity, strength, composition (21 CFR 111.70(e))
You did not establish product specifications for the purity, strength and composition of the finished dietary supplement.
Specifications met - component identity (21 CFR 111.73)
You did not determine whether you met identity specifications established for components.
Component - verify identity, dietary ingredient (21 CFR 111.75(a)(1)(i))
You did not conduct at least one appropriate test or examination to verify the identity of a dietary ingredient, prior to its use.
Tests, examinations - scientifically valid (21 CFR 111.75(h))
You did not ensure that the tests or examinations that you used to determine whether the specifications are met are appropriate, scientifically valid methods.
Quality control master manufacturing record; material review, disposition (21 CFR 111.113(a)(2))
Your quality control personnel did not conduct a material review and make a disposition decision when a batch deviated from the master manufacturing record.
Quality control operations - quarantine (21 CFR 111.120(e))
Your quality control operations did not include approving, and releasing from quarantine, all components and packaging before they were used.
FEI 3007844828
Show all 9 inspections
No action indicated · No objectionable conditions found
Inspected
Mckinney, Texas
FEI 3025065421
Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm
Inspected
Allen, Texas
10 citations posted:
- Registration (21 CFR 108.25(c)(1))
- Process filing (21 CFR 108.25(c)(2))
- Approved school (21 CFR 108.25(f))
- Specifications - components (21 CFR 111.70(b))
See all 10 citations
Registration (21 CFR 108.25(c)(1))
You did not register and file Form FDA 2541 (food canning establishment registration) with FDA within 10 days after first engaging in the manufacture, processing and packaging of acidified foods.
Process filing (21 CFR 108.25(c)(2))
You did not provide FDA with information on the scheduled process for a new acidified food before packing the food.
Approved school (21 CFR 108.25(f))
Personnel involved in acidification, pH control, heat treatment and critical factors of the operation were not under the operating supervision of a person who attended and satisfactorily completed a school approved by the FDA Commissioner.
Specifications - components (21 CFR 111.70(b))
For component(s) used in the manufacture of a dietary supplement, you did not establish identity specifications and necessary specifications to ensure the specifications for purity, strength, and composition of the dietary supplement are met.
Specifications - labels, packaging (21 CFR 111.70(d))
You did not establish label and packaging specifications.
Specifications - finished dietary supplement (21 CFR 111.70(e))
You did not establish product specifications for identity, purity, strength, composition and limits on contamination.
Quality control - processes, specifications, written procedures (21 CFR 111.105(a))
Your quality control personnel did not approve or reject specifications and written procedures that may affect the identity, purity, strength, or composition of a dietary supplement.
Master manufacturing record - record requirements (21 CFR 111.210)
Your master manufacturing record did not include all required information.
Batch record - required information (21 CFR 111.260)
Your batch production record did not include all required information.
Quality control procedures (21 CFR 114.80(a))
Appropriate quality control procedures are not employed to ensure that finished foods do not present a health hazard.
FEI 3007844828
Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm
Inspected
Allen, Texas
1 citation posted:
- Allergen preventive controls - Implement (21 CFR 117.135(a)(1))
Full citation text
Allergen preventive controls - Implement (21 CFR 117.135(a)(1))
You did not implement your allergen preventive control procedures.
FEI 3007844828
Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm
Inspected
Allen, Texas
1 citation posted:
- Appropriate tests, examinations; certificate of analysis (21 CFR 111.75(a)(2))
Full citation text
Appropriate tests, examinations; certificate of analysis (21 CFR 111.75(a)(2))
You did not conduct appropriate tests or examinations or rely on a certificate of analysis to determine whether components met established specifications.
FEI 3007844828
Official action indicated · Regulatory or administrative action recommended
Inspected
Allen, Texas
8 citations posted:
- Specifications - component identity (21 CFR 111.70(b)(1))
- Specifications-component purity, strength, composition (21 CFR 111.70(b)(2))
- Specifications - identity, purity, strength, composition (21 CFR 111.70(e))
- Specifications met - component identity (21 CFR 111.73)
See all 8 citations
Specifications - component identity (21 CFR 111.70(b)(1))
You did not establish an identity specification for each component.
Specifications-component purity, strength, composition (21 CFR 111.70(b)(2))
You did not establish component specifications for purity, strength and composition.
Specifications - identity, purity, strength, composition (21 CFR 111.70(e))
You did not establish product specifications for the purity, strength and composition of the finished dietary supplement.
Specifications met - component identity (21 CFR 111.73)
You did not determine whether you met identity specifications established for components.
Component - verify identity, dietary ingredient (21 CFR 111.75(a)(1)(i))
You did not conduct at least one appropriate test or examination to verify the identity of a dietary ingredient, prior to its use.
Tests, examinations - scientifically valid (21 CFR 111.75(h))
You did not ensure that the tests or examinations that you used to determine whether the specifications are met are appropriate, scientifically valid methods.
Quality control master manufacturing record; material review, disposition (21 CFR 111.113(a)(2))
Your quality control personnel did not conduct a material review and make a disposition decision when a batch deviated from the master manufacturing record.
Quality control operations - quarantine (21 CFR 111.120(e))
Your quality control operations did not include approving, and releasing from quarantine, all components and packaging before they were used.
FEI 3007844828
Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm
Inspected
Allen, Texas
7 citations posted:
- Specifications-component purity, strength, composition (21 CFR 111.70(b)(2))
- Component - verify identity, dietary ingredient (21 CFR 111.75(a)(1)(i))
- Quality control operations - master manufacturing record, modifications (21 CFR 111.123(a)(1))
- Packaging - quality control; tests, examination (21 CFR 111.160(c)(2))
See all 7 citations
Specifications-component purity, strength, composition (21 CFR 111.70(b)(2))
You did not establish component specifications for purity.
Component - verify identity, dietary ingredient (21 CFR 111.75(a)(1)(i))
You did not conduct at least one appropriate test or examination to verify the identity of a dietary ingredient, prior to its use.
Quality control operations - master manufacturing record, modifications (21 CFR 111.123(a)(1))
Your quality control operations did not include reviewing and approving master manufacturing records.
Packaging - quality control; tests, examination (21 CFR 111.160(c)(2))
Your quality control personnel did not review and approve the results of tests or examinations conducted on the packaging while the packaging was quarantined.
Labels - quality control; approve, release (21 CFR 111.160(c)(3))
Your quality control personnel did not approve labels for use in the manufacture of a dietary supplement and release them from quarantine.
Master manufacturing record - controls, procedures (21 CFR 111.205(b)(2))
Your master manufacturing record did not establish controls and procedures to ensure that each batch met specifications.
Packaging description, representative label (21 CFR 111.210(g))
Your master manufacturing record did not include a representative label, or a cross-reference to the physical location of the actual or representative label.
FEI 3007844828
Official action indicated · Regulatory or administrative action recommended
Inspected
Allen, Texas
10 citations posted:
- Production, process controls - implement (21 CFR 111.55)
- Specifications - component identity (21 CFR 111.70(b)(1))
- Specifications-component purity, strength, composition (21 CFR 111.70(b)(2))
- Specifications - labels, packaging (21 CFR 111.70(d))
See all 10 citations
Production, process controls - implement (21 CFR 111.55)
You did not implement a system of production and process controls that covers all stages of manufacturing, packaging, labeling, and holding of dietary supplements to ensure the quality of the dietary supplement.
Specifications - component identity (21 CFR 111.70(b)(1))
You did not establish an identity specification for each component.
Specifications-component purity, strength, composition (21 CFR 111.70(b)(2))
You did not establish component specifications for purity, strength, and composition.
Specifications - labels, packaging (21 CFR 111.70(d))
You did not establish label and packaging specifications.
Component - verify identity, dietary ingredient (21 CFR 111.75(a)(1)(i))
You did not conduct at least one appropriate test or examination to verify the identity of a dietary ingredient, prior to its use.
Specifications met - verify; finished batch (21 CFR 111.75(c))
You did not verify that your finished batch of dietary supplement meets product specifications for identity, purity, strength, composition, and limits on contamination that may adulterate or that may lead to adulteration of the dietary supplement.
Quality control operations - quarantine (21 CFR 111.120(e))
Your quality control operations did not include approving, and releasing from quarantine, all components, packaging, and labels before they were used.
Master manufacturing record - unique formulation (21 CFR 111.205(a))
You did not prepare a written master manufacturing record for each unique formulation of a dietary supplement that you manufactured.
Batch record - complete (21 CFR 111.255(b))
Your batch production record did not include complete information relating to the production and control of each batch.
Product complaint -investigate, findings, follow-up (21 CFR 111.560(c))
Your review about whether to investigate a product complaint and findings and follow-up action of an investigation performed did not extend to all relevant batches and records.
FEI 3007844828
Official action indicated · Regulatory or administrative action recommended
Inspected
Allen, Texas
FEI 3007844828
Official action indicated · Regulatory or administrative action recommended
Inspected
Allen, Texas
6 citations posted:
- Production, process controls - implement (21 CFR 111.55)
- Written procedures - labels (21 CFR 111.153)
- Labels - issuance, use (21 CFR 111.410(b))
- Records - packaging, labeling operations: 1 year, 2 years (21 CFR 111.430(a))
See all 6 citations
Production, process controls - implement (21 CFR 111.55)
You did not implement a system of production and process controls that covers all stages of manufacturing, packaging, labeling, and holding of dietary supplements to ensure the quality of the dietary supplement.
Written procedures - labels (21 CFR 111.153)
You did not establish written procedures for the requirements for labels received.
Labels - issuance, use (21 CFR 111.410(b))
You did not control the issuance and use of labels,
Records - packaging, labeling operations: 1 year, 2 years (21 CFR 111.430(a))
You did not keep the records required for your packaging and labeling operations for the required time period.
Written procedures - returned dietary supplement (21 CFR 111.503)
You did not establish written procedures for when a returned dietary supplement is received.
Written procedures - product complaint (21 CFR 111.553)
You did not establish written procedures for the requirements to review and investigate a product complaint.
FEI 3007844828
We match FDA inspections to companies by facility ZIP code (or city outside the US) and company name, so an inspection filed under a different name won’t appear here. FDA publishes final classifications only, and holds some back while enforcement is pending. Posted citations may differ from FDA’s final findings. FDA Data Dashboard · How we check
What we checked, and what we didn’t
Confirmed from public registry listings
Last checked
- NSF/ANSI 455-2 GMP certification
- Informed Manufacturer certified facility (not a GMP audit)
- USDA Organic certified operation
- 3 facility addresses
- Dosage forms in the listed scope
- Operations listed for each facility
Not verified by us
- Minimum order quantity (MOQ): the smallest order they accept
- Lead times and current capacity
- Prices
- Other certifications, like kosher, halal or NSF Certified for Sport
- Whether they’re taking new clients
- Conditions inside the facility. We don’t visit or audit facilities.
Ask about these in your quote request. How we verify
Other capsule manufacturers in the United States
NSF lists 5 capsule facilities, including one in Tempe, AZ
Tempe, AZ, United States21stcenturyvitamins.com
- Capsules
- Gummies
- Softgels
- Tablets
Operations:- Kitting
- Coating
- Tablet compression
- Encapsulation
NSF/ANSI 455-2checked Nov 19, 2026NSF lists a capsule facility in Centennial, CO
Centennial, CO, United States5280smc.com
- Capsules
Operations:- Encapsulation
- Dry formulation
NSF/ANSI 455-2checked Nov 19, 2026NSF lists a capsule facility in Garden Grove, CA
Garden Grove, CA, United Statespackaging.com
- Capsules
- Gummies
- Powders
- Softgels
- Tablets
NSF/ANSI 455-2checked Nov 19, 2026Access Business Group, LLC
USDA OrganicNSF lists a capsule facility in Ada, MI
Ada, MI, United Statesamway.com
- Capsules
- Powders
- Softgels
- Tablets
Operations:- Kitting
- Coating
- Tablet compression
- Encapsulation
- +1 more
NSF/ANSI 455-2checked Nov 19, 2026NSF lists 2 capsule facilities, including one in Chandler, AZ
Gilbert, AZ, United Statesadeptlifesciences.com
- Capsules
- Liquids
- Powders
- Tablets
Operations:- Liquid formulation
- Tablet compression
- Encapsulation
- Dry formulation
NSF/ANSI 455-2checked Nov 19, 2026ADH Health Products, Inc.
USDA OrganicNSF lists a capsule facility in Congers, NY
Congers, NY, United Statesadhhealth.com
- Capsules
- Oils
- Powders
- Tablets
Operations:- Coating
- Tablet compression
- Encapsulation
- Dry formulation
NSF/ANSI 455-2checked Nov 19, 2026